|  | eGFR (mL/min/1.73 m2) |  | ||
---|---|---|---|---|---|
 | All (n = 5,555) | ≥ 90.0 (n = 716) | 60.0-89.9 (n = 4,353) | 30.0-59.9 (n = 486) | Pfor trend |
Age | 46.5 ± 15.7 | 32.3 ± 12.1 | 46.5 ± 14.0 | 67.7 ± 9.9 | < 0.001 |
Male | 2,379 (100) | 456 (19.2) | 1,835 (77.1) | 88 (3.7) | Â |
Female | 3,176 (100) | 260 (8.2) | 2,518 (79.3) | 398 (12.5) | Â |
eGFR | 76.4 ± 12.2 | 96.7 ± 5.6 | 75.3 ± 8.2 | 55.9 ± 5.5 | < 0.001 |
Proteinuria (%) | Â | Â | Â | Â | 0.141 |
   Negative | 94.4 | 93.3 | 94.9 | 91.6 |  |
   Mild | 4.8 | 5.9 | 4.5 | 6.1 |  |
   Heavy | 0.8 | 0.7 | 0.6 | 2.3 |  |
Co-morbidities (%) | Â | Â | Â | Â | Â |
   Diabetes mellitus | 7.6 | 3.7 | 7.0 | 19.0 | < 0.001 |
   Hypertension | 25.3 | 11.0 | 24.1 | 55.3 | < 0.001 |
   Metabolic syndrome | 29.4 | 13.8 | 28.4 | 60.0 | < 0.001 |
   Anemia | 11.2 | 9.5 | 11.0 | 16.0 | 0.001 |
   Ischemic heart disease | 2.2 | 0.4 | 2.0 | 6.0 | < 0.001 |
   Cerebrovascular disease | 2.2 | 0.5 | 1.8 | 8.2 | < 0.001 |